OECD TG 415

OECD TG 415 is the standard for the ‘One-Generation Reproduction Toxicity Study’, i.e. the one-generation reproduction toxicity study, which is included in Section 4 (Health Effects) of the OECD Test Guidelines for the Testing of Chemicals. The test is designed to assess the effects of a test substance on male and female reproductive functions, pregnancy, parturition, lactation and the development of offspring over a single generation.

Note on regulatory status: OECD TG 415 has been superseded by the OECD and largely replaced by OECD TG 443 (Extended One-Generation Reproductive Toxicity Study, EOGRTS). Nevertheless, TG 415 continues to be used as a reference in certain regulatory frameworks when assessing older dossiers and interpreting historical data sets. For this reason, the service page covers both the scientific content of the guideline and its current practical application.

The basic principle of the test is to administer the test substance to male and female animals from the period prior to mating, to allow them to mate, and to observe the stages of pregnancy, birth and lactation. The assessment is usually carried out on rats. The offspring are monitored for developmental progress until weaning.

The key parameters assessed in the study are as follows:

Parent generation (P) – Reproductive function:

  • Gonadal function and the oestrus cycle
  • Mating behaviour and mating index
  • Fertility and conception rates
  • Sperm parameters (count, motility, morphology)
  • Histopathological examination of the reproductive organs

Pregnancy and childbirth:

  • Gestation period and gestation index
  • Labour and delivery and live birth rate
  • Data on resorption, stillbirths and implantation

Next generation (F1):

  • Live births and survival after birth
  • Body weight and growth chart
  • Indicators of physical development
  • Clinical observations prior to weaning
  • Where appropriate, recording of gender distribution and developmental abnormalities

The study design shall include a negative control group, a solvent control group and, where appropriate, a positive control group; dosages, group size and duration of treatment shall be justified in accordance with the regulatory requirements of OECD TG 415.

Why is the study being carried out?

The OECD TG 415 is being carried out for the following scientific and regulatory purposes:

Assessment of reproductive toxicity: determination of the effects of the test substance on male and female fertility

Assessment of developmental effects: identification of effects occurring during pregnancy, birth and lactation

Monitoring the development of the next generation: Assessment of postnatal survival and growth parameters in the F1 generation

Support for regulatory dossiers: Use in safety assessments of chemicals, pesticides, biocidal products and industrial chemicals

Analysis of historical data: Evaluation of existing TG 415 studies within the current regulatory context and comparison with TG 443 data

The ‘weight-of-evidence’ approach: a contribution to risk assessment in conjunction with other data on reproductive and developmental toxicity, physicochemical properties and exposure assessment

OECD TG 415 does not, on its own, cover the entire reproductive toxicity profile. Its informative value is limited with regard to transgenerational effects, functional developmental endpoints and endocrine effects; therefore, current regulatory assessments are based on TG 443 and the associated guidelines. The results should be interpreted within the context of a holistic toxicological assessment.

As part of our nano-testing services, we carry out tests in accordance with OECD TG 415 and the procedures set out in OECD TG 443 – the current equivalent of this standard – with scientific rigour within our accredited laboratory facilities and under our quality management system. Our scope of services includes the following:

Experimental design and protocol preparation

Preparation of a test report in accordance with OECD TG 415 and its current equivalent, OECD TG 443

Determination of the dosage range and definition of the main experimental design in accordance with the physicochemical properties of the test substance

Definition of negative controls, solvent controls and, where appropriate, suitable positive control groups; scientific justification for the choice of species, route of administration, dosage levels and duration of treatment; compliance with requirements regarding ethical approval and animal welfare

For your studies under OECD TG 415 and its current equivalent, OECD TG 443, you can contact Nano-Test to obtain information on study design, species selection, sample acceptance criteria, test schedules and reporting procedures. We also offer scientific advice on evaluating your existing TG 415 data within the current regulatory context, as well as on the strategy for transitioning to TG 443.